Effects of Transcranial Direct Current Stimulation on Balance of Children With Balance Deficit

NCT04341220 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2020-04-10

No results posted yet for this study

Summary

Neural control of posture depends on interaction of sensory and motor information from multiple structures, including the primary motor cortex (M1). Transcranial direct current stimulation (TDCS) improves postural control in children and adults with and without neurological disorders, however, additive effects to physical therapy treatment are still unknown, specifically balance exercises for children with balance deficit. The aim of this study is to identify the effects of adding anodic TDCS over M1 to exercises on postural control of children with balance deficit. This is a randomized, double-blind, controlled clinical trial.

Conditions

  • Postural Balance

Interventions

DEVICE

Transcranial direct current stimulation (tDCS)

Transcranial direct current stimulation is a noninvasive technique of neuronal modulation.

OTHER

Balance exercises

Specific balance exercises, focused on balance, postural control and control of the center of gravity within the support base.

Sponsors & Collaborators

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

    collaborator OTHER_GOV
  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Renata Hydee Hasue · Faculty of Medicine, University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-20
Primary Completion
2020-12-31
Completion
2021-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04341220 on ClinicalTrials.gov